Presepsin as a predictive biomarker of severity in COVID-19: A case series

J Med Virol. 2021 Jan;93(1):99-101. doi: 10.1002/jmv.26164. Epub 2020 Jun 24.

Authors

Affiliations

¹ Department of Clinical Laboratory, Saitama Medical University Hospital, Saitama, Japan.
² Department of Infectious Disease and Infection Control, Saitama Medical University, Saitama, Japan.
³ Department of Laboratory Medicine, Saitama Medical University, Saitama, Japan.

No abstract available

Publication types

Letter

MeSH terms

Biomarkers / blood
C-Reactive Protein / metabolism
COVID-19 / blood*
COVID-19 / pathology*
Humans
Lipopolysaccharide Receptors / blood*
Lipopolysaccharide Receptors / genetics
Lipopolysaccharide Receptors / metabolism
Mucin-1 / blood
Mucin-1 / metabolism
Peptide Fragments / blood*
Peptide Fragments / genetics
Peptide Fragments / metabolism
Retrospective Studies
SARS-CoV-2*

Substances

Biomarkers
Lipopolysaccharide Receptors
MUC1 protein, human
Mucin-1
Peptide Fragments
presepsin protein, human
C-Reactive Protein